Table 3.
Treatment | Dose (mg/ml) | Normalised survival time (hour) in mean ± SD | t value | t critical value |
---|---|---|---|---|
Control | 0 | 100.00 ± 0.97 | NA | NA |
Albendazole | 1.25 | 043.54 ± 0.97* | 159.16 | 2.05 |
2.5 | 036.74 ± 0.83* | 192.16 | 2.05 | |
5 | 026.15 ± 0.72* | 236.69 | 2.06 | |
10 | 008.12 ± 0.92* | 266.53 | 2.05 | |
20 | 001.81 ± 0.38* | 365.24 | 2.10 | |
I. cylindrica extract | 1.25 | 095.67 ± 1.77* | 008.30 | 2.07 |
2.5 | 090.13 ± 1.63* | 020.13 | 2.07 | |
5 | 084.46 ± 1.10* | 040.99 | 2.05 | |
10 | 082.94 ± 2.11* | 028.42 | 2.09 | |
20 | 081.56 ± 1.71* | 036.43 | 2.07 |
NA Not applicable; n = 15; t value is the calculated difference represented in units of standard error, the higher the value, the greater the evidence against the null hypothesis; t critical value denotes the value that must be exceeded to get a significant level
*Significantly different at p < 0.05 against control